Merck & Co. won dismissal of the second case scheduled for trial over claims its osteoporosis drug Fosamax caused so-called jaw death. U.S. District Judge John Keenan in Manhattan ruled in Merck’s favor in an opinion Monday. Keenan said that ...
Tagged with: Fosomax jaw death Merck
Read More »